FDA Inspection 1179906 - Central Pennsylvania Blood Bank Headquarters - September 01, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Central Pennsylvania Blood Bank Headquarters, with an inspection on September 1, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Central Pennsylvania Blood Bank Headquarters
Inspection Date: September 1, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · b5bbb691-ac48-4a3e-868d-faa17e9cde69